Clinical Trial Information

Role of Canagliflozin on gene expression and function of CD34+ endothelial progenitor cells in patients with type 2 diabetes and mild chronic kidney disease (Stages 1-2, CKD)

Study Details

We are looking to see if Invokana, an FDA Approved Type 2 Diabetes medication, can help improve kidney function and cardiovascular health. We are looking for patients aged 40-70 years with Type 2 Diabetes who are taking Metformin (1000-2000mg). Your HbA1C should be between 7 ‚Äì 10 %.

Primary Sponsor:

Janssen Pharmaceuticals, Inc.

Prinicipal Investigator:

Sabyasachi Sen, MD/Endocrinology

Contact Phone:

(202) 741-2342

Interested in More Information

First Name

Please enter your first name.
Last Name

Please enter your last name.
Email:

This isn't a valid email address.

Please enter your email address.
Phone

This isn't a valid phone number.

Please enter your phone number.

You entered an invalid number.
Address

Please enter your address.
City

Please enter your city.
Select State

Please enter your state.
Zip Code

Please enter your zip code.
Verification Code * (All Uppercase. No Spaces)